[MAP in the therapy of adenocarcionoma of the endometrium. Immediate clinical results and general endocrine effects].
D000230:Adenocarcinoma / Q000188:drug therapy*; D004702:Endocrine Glands / Q000187:drug effects; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy*
D008525:Medroxyprogesterone
Ii MAP nella terapia dell'adenocracinoma dell'endometrio. Risultati clinici immediati ed effetti endocrini generali